A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis

NCT01709656 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

BIOLOGICAL: MSC
DRUG: "celecoxib", "Celebrex®"

Sponsor

Sun Yat-sen University